Editorial policy
We publish prices, the terms attached to them, and the rules that affect them. Each claim has a source and a date. We do not publish medical guidance.
Last revised 20 Nov 2026
Sources
- A price comes from the seller's own page. We link to that page and show the date we read it.
- A statement about law or regulation comes from the body that made it: the FDA, the Centers for Medicare & Medicaid Services, a court or the Federal Register. We link to the document.
- A statement about a manufacturer's terms comes from the manufacturer's page or press release.
- When we rely on a secondary source, we say so in the sentence.
- If we cannot source a claim, we leave it out. If a fact is unsettled, we say what we do not know.
Every source page is listed under sources.
Dates
A price page shows when its prices were last checked. A guide shows two dates: when its prices were checked and when its text was last changed. We change the “article updated” date only when the text changes.
Wording about medicines
- We state what a drug is approved for in the words of its FDA label, and link to it: Zepbound and Mounjaro. The two have different approved uses and we do not blur them.
- We make no claims about how well a drug works and publish no weight-loss figures, testimonials or before-and-after images.
- We give no advice on dose. Where a page mentions the label's dose steps, it describes them as the label's.
- We write “compounded tirzepatide”. We never call it a generic or describe it as equivalent to an FDA-approved product. Wherever compounded products appear, the page says they are not FDA-approved. The FDA lists claims of sameness with an approved drug among the practices it treats as misleading (FDA, page current as of 15 June 2026).
- Labels such as “lowest price” describe price and access only.
Independence
- Lists are ordered by price. Commission does not affect order, wording or which sellers appear.
- Sellers do not see pages before they are published and cannot pay for coverage.
- We list a seller's drawbacks next to its price, including fees that rise after the first month.
- Where the FDA has sent a seller a warning letter that we have read on fda.gov, the seller's page says so and links to the letter.
How the site earns money is set out on how we make money.
Authors and review
Pages are produced by the Tirzepatide Price data desk. We do not attribute pages to named individuals yet and we do not invent bylines. There is no medical reviewer, because the site reports prices and publishes no medical guidance.
Automation
Scripts read seller pages and compare prices. Software, including AI models, helps draft and check text. A price that moves more than 60% is held for a person to check. The methodology has the detail.
What we do not publish
- Reader reviews, star ratings or scores for sellers.
- Sponsored articles or paid placements.
- Countdown timers, stock warnings or other pressure to buy.
- Prices for substances the FDA says cannot be used in compounding.
Corrections
We fix errors and log each fix with its date on the corrections page. A price that changes at the seller is not a correction. It goes in the price history.